High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: A matter of time?
作者信息
Barrasa Helena, Martín Alejandro, Maynar Javier, Rello Jordi, Fernández-Torres Marina, Aguirre-Quiñonero Amaia, Canut-Blasco Andrés
机构信息
Bioaraba, Intensive Care Unit, Vitoria-Gasteiz, Spain; Osakidetza Basque Health Service, Araba University Hospital, Intensive Care Unit, Vitoria-Gasteiz, Spain.
Bioaraba, Intensive Care Unit, Vitoria-Gasteiz, Spain; Osakidetza Basque Health Service, Araba University Hospital, Intensive Care Unit, Vitoria-Gasteiz, Spain.
出版信息
J Infect. 2021 May;82(5):186-230. doi: 10.1016/j.jinf.2020.12.001. Epub 2020 Dec 5.
Abstract
摘要
相似文献
1
High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: A matter of time?重症 SARS-CoV-2 肺炎患者入住重症监护病房期间感染率高：只是时间问题？
J Infect. 2021 May;82(5):186-230. doi: 10.1016/j.jinf.2020.12.001. Epub 2020 Dec 5.
2
Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx).感染新型冠状病毒2（SARS-CoV-2）的孕妇死亡和患肺炎风险更高：一项全国性前瞻性队列（COV19Mx）的倾向评分匹配分析
Ultrasound Obstet Gynecol. 2021 Feb;57(2):224-231. doi: 10.1002/uog.23575.
3
Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea.韩国2019冠状病毒病儿科患者的特征。
J Korean Med Sci. 2021 May 24;36(20):e148. doi: 10.3346/jkms.2021.36.e148.
4
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection.国家早期预警评分 2（NEWS2）对 SARS-CoV-2 感染患者入住重症监护病房的预测价值。
Infect Dis (Lond). 2020 Oct;52(10):698-704. doi: 10.1080/23744235.2020.1784457. Epub 2020 Jun 25.
5
Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumonia.凝血酶原时间延长作为新型冠状病毒肺炎相关肺炎患者严重急性呼吸窘迫综合征的早期预后指标
Curr Med Res Opin. 2021 Jan;37(1):21-25. doi: 10.1080/03007995.2020.1853510. Epub 2020 Dec 7.
6
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
7
Timing and causes of death in severe COVID-19 patients.严重 COVID-19 患者的死亡时间和原因。
Crit Care. 2021 Jun 30;25(1):224. doi: 10.1186/s13054-021-03639-w.
8
Racial and Ethnic Disparities in Rates of COVID-19-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021.2020 年 3 月至 2021 年 2 月期间美国 COVID-19 相关住院率、重症监护病房入院率和住院死亡率的种族和民族差异。
JAMA Netw Open. 2021 Oct 1;4(10):e2130479. doi: 10.1001/jamanetworkopen.2021.30479.
9
Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study.埃及某大学医院重症监护病房收治的2019冠状病毒病（COVID-19）肺炎患者的死亡结局及危险因素。一项回顾性队列研究。
J Infect Public Health. 2021 Oct;14(10):1381-1388. doi: 10.1016/j.jiph.2021.06.012. Epub 2021 Jun 25.
10
Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.感染 SARS-CoV-2 的非甾体抗炎药使用者的不良结局和死亡率：一项丹麦全国队列研究。
PLoS Med. 2020 Sep 8;17(9):e1003308. doi: 10.1371/journal.pmed.1003308. eCollection 2020 Sep.
引用本文的文献
1
Determinants of COVID-19 severity and mortality in children: A retrospective and multicenter cohort study in Medan, Indonesia.儿童新冠病毒病严重程度和死亡率的决定因素：印度尼西亚棉兰的一项回顾性多中心队列研究。
Narra J. 2024 Aug;4(2):e865. doi: 10.52225/narra.v4i2.865. Epub 2024 Aug 8.
2
Bacterial Community- and Hospital-Acquired Pneumonia in Patients with Critical COVID-19-A Prospective Monocentric Cohort Study.重症新型冠状病毒肺炎患者的细菌群落与医院获得性肺炎——一项前瞻性单中心队列研究
Antibiotics (Basel). 2024 Feb 16;13(2):192. doi: 10.3390/antibiotics13020192.
3
Healthcare-associated infections in critical COVID-19 patients in Tunis: epidemiology, risk factors, and outcomes.突尼斯重症新冠肺炎患者的医疗相关感染：流行病学、危险因素及结局
Acute Crit Care. 2023 Nov;38(4):425-434. doi: 10.4266/acc.2023.00773. Epub 2023 Nov 28.
4
A Systematic Review of Antimicrobial Resistance During the COVID-19 Pandemic.COVID-19 大流行期间的抗菌药物耐药性系统评价
Hawaii J Health Soc Welf. 2023 Aug;82(8):188-193.
5
Management of hypoxemia in SARS-CoV-2 infection: Lessons learned from one year of experience, with a special focus on silent hypoxemia.新型冠状病毒2型感染中低氧血症的管理：从一年经验中吸取的教训，特别关注隐性低氧血症。
J Intensive Med. 2021 Mar 9;1(1):26-30. doi: 10.1016/j.jointm.2021.02.001. eCollection 2021 Jul.
6
Value of syndromic panels in the management of severe community-acquired pneumonia.症候群检测套组在严重社区获得性肺炎治疗上的价值。
Rev Esp Quimioter. 2022 Apr;35 Suppl 1(Suppl 1):15-20. doi: 10.37201/req/s01.03.2022. Epub 2022 Apr 22.
7
Coinfection and superinfection in SARS-CoV-2 pneumonia. Two underestimated threats. The need of empirical treatment under debate.新型冠状病毒肺炎中的合并感染和重叠感染。两个被低估的威胁。经验性治疗的必要性存在争议。
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Apr;40(4):155-157. doi: 10.1016/j.eimce.2022.02.011.
8
Health care-associated infections in patients with COVID-19 pneumonia in COVID critical care areas.新冠重症监护区域中新冠肺炎患者的医疗保健相关感染
Med Intensiva (Engl Ed). 2022 Apr;46(4):221-223. doi: 10.1016/j.medine.2021.04.013.
9
Coinfection and superinfection in SARS-CoV-2 pneumonia. Two underestimated threats. The need of empirical treatment under debate.新型冠状病毒肺炎中的合并感染和重叠感染。两种被低估的威胁。经验性治疗的必要性存在争议。
Enferm Infecc Microbiol Clin. 2022 Apr;40(4):155-157. doi: 10.1016/j.eimc.2022.02.002. Epub 2022 Mar 1.
10
High Rates of Bacterial Pulmonary Co-Infections and Superinfections Identified by Multiplex PCR among Critically Ill COVID-19 Patients.多重PCR在危重症COVID-19患者中发现的细菌肺部合并感染和重叠感染率高。
Microorganisms. 2021 Nov 30;9(12):2483. doi: 10.3390/microorganisms9122483.
本文引用的文献
1
Procalcitonin and secondary bacterial infections in COVID-19: association with disease severity and outcomes.降钙素原与新型冠状病毒肺炎继发细菌感染：与疾病严重程度及预后的关联
Acta Clin Belg. 2022 Apr;77(2):268-272. doi: 10.1080/17843286.2020.1824749. Epub 2020 Sep 23.
2
Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19.在新冠肺炎危重症患者中，合并感染发生率低，但重症监护病房获得性感染发生率高。
J Infect. 2021 Feb;82(2):e20-e21. doi: 10.1016/j.jinf.2020.09.010. Epub 2020 Sep 19.
3
Bacterial and fungal superinfections in critically ill patients with COVID-19.新型冠状病毒肺炎重症患者的细菌和真菌二重感染
Intensive Care Med. 2020 Nov;46(11):2071-2074. doi: 10.1007/s00134-020-06219-8. Epub 2020 Sep 9.
4
Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU.入住法国重症监护病房的重症新型冠状病毒肺炎患者的细菌和病毒合并感染
Ann Intensive Care. 2020 Sep 7;10(1):119. doi: 10.1186/s13613-020-00736-x.
5
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.COVID-19 住院患者合并感染和再感染的发生率：一项回顾性队列研究。
Clin Microbiol Infect. 2021 Jan;27(1):83-88. doi: 10.1016/j.cmi.2020.07.041. Epub 2020 Jul 31.
6
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis.COVID-19 患者的细菌合并感染和继发感染：一项实时快速综述和荟萃分析。
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629. doi: 10.1016/j.cmi.2020.07.016. Epub 2020 Jul 22.
7
Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis.新冠重症患者的合并感染与抗生素管理：一项前瞻性队列分析
Crit Care. 2020 Jul 9;24(1):410. doi: 10.1186/s13054-020-03135-7.
8
Co-infections in people with COVID-19: a systematic review and meta-analysis.COVID-19 患者合并感染：系统评价和荟萃分析。
J Infect. 2020 Aug;81(2):266-275. doi: 10.1016/j.jinf.2020.05.046. Epub 2020 May 27.
9
SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria.西班牙重症监护病房中的 SARS-CoV-2：维多利亚 15 天生存的早期经验。
Anaesth Crit Care Pain Med. 2020 Oct;39(5):553-561. doi: 10.1016/j.accpm.2020.04.001. Epub 2020 Apr 9.
10
A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients.一种用于诊断危重症患者侵袭性肺曲霉病的临床算法。
Am J Respir Crit Care Med. 2012 Jul 1;186(1):56-64. doi: 10.1164/rccm.201111-1978OC. Epub 2012 Apr 19.
Zotero 插件